InvestorsObserver
×
News Home

Does MacroGenics Inc (MGNX) Have What it Takes to be in Your Portfolio Monday?

Monday, November 27, 2023 11:26 AM | InvestorsObserver Analysts

Mentioned in this article

Does MacroGenics Inc (MGNX) Have What it Takes to be in Your Portfolio Monday?

MacroGenics Inc (MGNX) is around the top of the Biotechnology industry according to InvestorsObserver. MGNX received an overall rating of 78, which means that it scores higher than 78 percent of all stocks. MacroGenics Inc also achieved a score of 94 in the Biotechnology industry, putting it above 94 percent of Biotechnology stocks. Biotechnology is ranked 53 out of the 148 industries.

Overall Score - 78
MGNX has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on MGNX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With MacroGenics Inc Stock Today?

MacroGenics Inc (MGNX) stock is trading at $7.48 as of 11:14 AM on Monday, Nov 27, a decline of -$0.02, or -0.27% from the previous closing price of $7.50. The stock has traded between $7.36 and $7.65 so far today. Volume today is low. So far 87,007 shares have traded compared to average volume of 730,883 shares. Click Here to get the full Stock Report for MacroGenics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App